Overview

Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients.

Status:
Completed
Trial end date:
2021-05-25
Target enrollment:
Participant gender:
Summary
This prospective monocentric phamacokinetics study aims to compare plasmatic concentrations of Propofol and Remifentanil required to target a specific range of monitored anesthesia and analgesia during sus-mesocolic surgery in obese and non obese patients.
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Treatments:
Propofol
Remifentanil